Corticosterone Dysregulation Exacerbates Disease Progression in the R6/2 Transgenic Mouse Model of Huntington's Disease

Experimental Neurology - United States
doi 10.1016/j.expneurol.2016.06.028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CD200 Is Up-Regulated in R6/1 Transgenic Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2019English

Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice

Neurobiology of Disease
Neurology
2001English

Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2013English

Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease

Journal of Neurophysiology
NeurosciencePhysiology
2006English

Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2014English

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease

PLoS ONE
Multidisciplinary
2016English

N-Acetylcysteine Improves Mitochondrial Function and Ameliorates Behavioral Deficits in the R6/1 Mouse Model of Huntington's Disease

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2015English

Ceftriaxone-Induced Up-Regulation of Cortical and Striatal GLT1 in the R6/2 Model of Huntington's Disease

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2010English

XJB-5-131-mediated Improvement in Physiology and Behaviour of the R6/2 Mouse Model of Huntington's Disease Is Age- And Sex- Dependent

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy